TITLE

Current Strategies for the Development of Novel Antipsychotic Drugs

AUTHOR(S)
J. Bolos
PUB. DATE
May 2003
SOURCE
Mini Reviews in Medicinal Chemistry;May2003, Vol. 3 Issue 3, p239
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
While classical neuroleptics are characterized by dopamine D2 antagonism, this is also considered to be the cause of their neurological side effects. In recent years, novel antipsychotic drugs with improved efficacy, devoid of extrapyramidal effects are being developed. The mechanisms of action of these new atypical antipsychotics can be classified into three general groups: a) binding to D2 together with non-dopaminergic receptors, b) interaction with dopamine receptor subtypes other than D2 and c) selective binding to nondopaminergic systems, such as glutamatergic, sigma, neurotensin, and cannabinoid.
ACCESSION #
10492208

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics